Login / Signup

Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III.

Yang LiuYang ChenSteven H M LamBi HuangGiulio Francesco RomitiUazman AlamTze Fan ChaoBrian OlshanskyKui HongMenno V HuismanGregory Yoke Hong Lipnull null
Published in: Diabetes, obesity & metabolism (2024)
DM was independently associated with higher risks of all-cause death, CV death, MI, major bleeding and MACE in AF individuals. Individuals receiving insulin alone were associated with higher risks of all-cause death, CV death, MI, major bleeding and MACE.
Keyphrases
  • atrial fibrillation
  • phase iii
  • type diabetes
  • clinical trial
  • open label
  • human health
  • randomized controlled trial
  • phase ii
  • placebo controlled
  • study protocol